The International Stroke Conference features the annual dissemination of the latest stroke and brain health science to researchers, clinicians, and scientists. It is hosted by the American Heart Association/American Stroke Association.
NeuroVoices: Shazam Hussain, MD, FRCP, FAHA, on Weighing Direct to Angio Approaches for Mobile Stroke UnitsFebruary 22nd 2023
The director of Cleveland Clinic’s Cerebrovascular Center provided clinical perspective on the treatment decisions mobile stroke units face, and whether directly transferring patients to angiography suite is necessary.
Expanding the Window to Use Mechanical Thrombectomy, Treat Ischemic Stroke: Gabor Toth, MDFebruary 17th 2023
The vascular and interventional neurologist at Cleveland Clinic provided insight on a study presented at the 2023 International Stroke Conference that observed the clinical effectiveness of mechanical thrombectomy beyond 24 hours. [WATCH TIME: 6 minutes]
Advantages to Directly Transferring Stroke Treatment to Angiography: Shazam Hussain, MD, FRCP, FAHAFebruary 14th 2023
The director of Cleveland Clinic’s Cerebrovascular Center discussed the decisions mobile stroke units face and why opting for direct transfer to angiography is meant for certain scenarios. [WATCH TIME: 3 minutes]
Understanding Nuances of Mobile Stroke Units and When to Transfer Directly to Angiography: Shazam Hussain, MD, FRCP, FAHAFebruary 13th 2023
The director of Cleveland Clinic’s Cerebrovascular Center provided perspective on a new study presented at the International Stroke Conference on experiences of poststroke patients taken directly to angiography suite. [WATCH TIME: 3 minutes]
Blood Pressure Medications Not Safe or Effective in Lowering Top Number of BP Reading After Endovascular Stroke TreatmentFebruary 10th 2023
Blood pressure medications may not be safe or effective to use for lowering systolic blood pressure following endovascular treatment for acute ischemic stroke.
Stroke Prevention and Atrial Fibrillation Management, Thoughts From STROKE-AF Study: Lee Shwamm, MDFebruary 10th 2023
The professor of neurology at Harvard Medical School spoke at the 2023 ISC Conference about highlights from the STROKE-AF study after a 3-year follow-up. [WATCH TIME: 5 minutes]
Direct Transfer to Angiography Following Mobile Stroke Unit Leads to Less Successful Recanalization, Increased MortalityFebruary 10th 2023
In comparison with those who underwent additional imaging, patients with large vessel occlusion who directly went to angiography suite had higher mortality, but with no difference in functional outcome.
Combination of Higher Dose ApTOLL and EVT Reduces Mortality and Disability in Ischemic StrokeFebruary 9th 2023
At the conclusion of the trial, treatment with 0.2 mg/kg of ApTOLL with EVT resulted in reduced brain edema and hemorrhagic transformation, as well as fewer deaths than placebo and 0.05 mg groups.
3-Year Follow-Up of STROKE-AF Demonstrates Stroke Risk Increase With Atrial FibrillationFebruary 9th 2023
Patients with noncardioembolic ischemic stroke do not typically monitor post-stroke longterm to detect atrial fibrillation although findings from a trial follow-up suggest otherwise.
NeuroVoices: Shumei Man, MD, on How Collaboration Between Hospitals Reduces Readmission for StrokeFebruary 8th 2023
The medical director of stroke at Fairview Hospital, an affiliate of Cleveland Clinic, provided perspective on a new intervention that improves communication and reduces hospital readmission for stroke.
EVT Reduces Physical Limitations, Improves 90-Day Outcomes Over Standard Therapy in Severe StrokeFebruary 13th 2022
A greater proportion of those treated with EVT had modified Rankin Scale scores of 0-3 at 90 days and NIHSS improvements of at least 8 points or more at 48 hours, relative to standard medical therapy.
DOAC Treatment a Reasonable Alternative to Warfarin for Patients With CVTFebruary 10th 2022
When compared with warfarin, treatment with DOACs was associated with a favorable safety profile, as well as similar clinical and radiographic outcomes in patients with cerebral venous thrombosis.
Deep Learning Algorithm Shows High Accuracy in Predicting ICH Hematoma ExpansionFebruary 10th 2022
The artificial neural network demonstrated an area under the precision-recall curve of 0.92 with recall of 0.72 with precision of 0.39 during testing, all values that were greater than classic regression models.
Eptifibatide During Endovascular Therapy May Increase Risk of Parenchymal Hematoma Hemorrhage in LVO StrokeFebruary 10th 2022
After small studies suggested eptifibatide may be safe in acute ischemic stroke, new data showed similar rates of ICH between study drug and controls, but increased PH-2 for those treated with the antiplatelet.
NeuroVoices: Ralph Sacco, MD, MS, on Improving Disparities and Expanding Research in Stroke CareApril 14th 2021
The chair of neurology and Olemberg Family Chair of Neurological Disorders at the University of Miami Miller School of Medicine discussed solutions to improve disparities in stroke care and the need for future research on social determinants of health.
Need for Research on Social Determinants of Health for Stroke Outcomes: Ralph Sacco, MD, MS, FAAN, FAHAApril 9th 2021
The chair of neurology and Olemberg Family Chair of Neurological Disorders at the University of Miami Miller School of Medicine detailed the reasons behind the lack of research on social determinants of health on stroke outcomes.
Improving Racial and Ethnic Disparities in Stroke Care: Ralph Sacco, MD, MS, FAAN, FAHAApril 7th 2021
The chair of neurology and Olemberg Family Chair of Neurological Disorders at the University of Miami Miller School of Medicine provided plans of action to reduce racial and ethnic disparities in stroke.
NeuroVoices: Ralph Sacco, MD, MS, on Florida Stroke Registry, Advancing Stroke KnowledgeMarch 31st 2021
The chair of neurology and Olemberg Family Chair of Neurological Disorders at the University of Miami Miller School of Medicine discussed the abundance of research from the Florida Stroke Registry presented at ISC 2021.